Alternatives
Alternatives to Imuldosa 130 mg/26 mL injection
There are 9 alternatives to this medicine in the catalogue: the same active ingredient (Ustekinumab), strength (130 mg/26 mL) and dosage form (injection) from 9 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Imuldosa 130 mg/26 mL injectionThis pageIntravenous | Accord BioPharmaIndia | US FDA | 1 vial of 26 mL | Cold chain | On request | — | Available on request |
| Ustekinumab 130 mg/26 mL injectionIntravenous | — | US FDA | 1 vial of 26 mL, 1 vial of 26 mL | Cold chain | On request | — | Available on request |
| Otulfi 130 mg/26 mL injectionIntravenous | Fresenius Kabi | US FDA | 1 vial of 26 mL | Cold chain | On request | — | Available on request |
| Pyzchiva 130 mg/26 mL injectionIntravenous | Sandoz | US FDA | 1 vial of 26 mL | Cold chain | On request | — | Available on request |
| Selarsdi 130 mg/26 mL injectionIntravenous | Teva Pharmaceuticals | US FDA | 1 vial of 26 mL | Cold chain | On request | — | Available on request |
| Starjemza 130 mg/26 mL injectionIntravenous | Hikma Pharmaceuticals | US FDA | 26 mL | Cold chain | On request | — | Available on request |
| Stelara 130 mg/26 mL injectionIntravenous | Janssen Biotech | US FDA | 1 vial of 26 mL | Cold chain | On request | — | Available on request |
| Steqeyma 130 mg/26 mL injectionIntravenous | Celltrion | US FDA | 1 vial of 26 mL | Cold chain | On request | — | Available on request |
| Wezlana 130 mg/26 mL injectionIntravenous | Nuvaila | US FDA | 1 vial of 26 mL | Cold chain | On request | — | Available on request |
| Yesintek 130 mg/26 mL injectionIntravenous | Biocon BiologicsIndia | US FDA | 1 vial of 26 mL | — | On request | — | Available on request |
This is a biological medicine. Products from other makers are biosimilars, not identical copies, and switching between them follows the prescriber's and regulator's rules.
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Imuldosa 130 mg/26 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.